Lymphoma, Cancer Sufferers Want More Information from Physicians

According to a new study published in Cancer, the peer-review journal of the American Cancer Society, people suffering from lymphoma, breast cancer and colon cancer overwhelmingly desire to have access to their organized medical record (OMR.

In order to come to their conclusions, researchers utilized a randomized study of 350 patients who had recently been diagnosed with lymphoma, breast cancer or colon cancer. These individuals were asked to describe the level of their need to view their OMR at their leisure, and the results were documented. As per the results of the surveys, a staggering 98 percent of the people polled admitted that their treatment experiences would benefit from access to the information.

Apparently, the freedom to get this information offered sufferers peace of mind. The respondents all made it a point to indicate that their anxiety would be sufficiently reduced if they could get access to their OMRs in a timely fashion and when they wanted to see them.

The study results even went so far as to suggest that physicians who for whatever reason believe that allowing patients to see their results would somehow increase stress and be detrimental to their mental health are mistaken.

People who had access to their information, the results showed, were 1.69 times more likely to feel satisfied with their prognosis and 1.86 times more likely to feel like they were completely and totally informed regarding their situation.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap